Johnson & White Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.06M | Sell |
5,694
-23
| -0.4% | -$4.27K | 0.53% | 44 |
|
2025
Q1 | $1.2M | Buy |
5,717
+54
| +1% | +$11.3K | 0.67% | 36 |
|
2024
Q4 | $1.02M | Sell |
5,663
-453
| -7% | -$81.3K | 0.61% | 38 |
|
2024
Q3 | $1.21M | Buy |
6,116
+242
| +4% | +$47.8K | 1.04% | 24 |
|
2024
Q2 | $1.01M | Buy |
5,874
+443
| +8% | +$76K | 0.96% | 25 |
|
2024
Q1 | $989K | Buy |
5,431
+436
| +9% | +$79.4K | 0.72% | 37 |
|
2023
Q4 | $774K | Buy |
4,995
+198
| +4% | +$30.7K | 0.64% | 40 |
|
2023
Q3 | $715K | Buy |
4,797
+108
| +2% | +$16.1K | 0.65% | 39 |
|
2023
Q2 | $632K | Buy |
4,689
+167
| +4% | +$22.5K | 0.87% | 24 |
|
2023
Q1 | $721K | Buy |
+4,522
| New | +$721K | 0.64% | 37 |
|
2022
Q4 | – | Sell |
-1,745
| Closed | -$234K | – | 78 |
|
2022
Q3 | $234K | Buy |
+1,745
| New | +$234K | 0.26% | 68 |
|